The autophagic tumor stroma model of cancer

A loss of stromal Cav-1 in the tumor fibroblast compartment is associated with early tumor recurrence, lymph-node metastasis, and tamoxifen-resistance, resulting in poor clincical outcome in breast cancer patients. Here, we have used Cav-1 (-/-) null mice as a pre-clinical model for this "lethal tumor micro-environment." Metabolic profiling of Cav-1 (-/-) mammary fat pads revealed the upregulation of numerous metabolites (nearly 100), indicative of a major catabolic phenotype. Our results are consistent with the induction of oxidative stress, mitochondrial dysfunction, and autophagy/mitophagy. The two most prominent metabolites that emerged from this analysis were ADMA (asymmetric dimethyl arginine) and BHB (beta-hydroxybutyrate; a ketone body), which are markers of oxidative stress and mitochondrial dysfunction, respectively. Transcriptional profiling of Cav-1 (-/-) stromal cells and human tumor stroma from breast cancer patients directly supported an association with oxidative stress, mitochondrial dysfunction, and autophagy/mitophagy, as well as ADMA and ketone production.

[1]  I. Kimura,et al.  STUDIES ON THE TREATMENT OF MALIGNANT TUMORS WITH FIBROBLAST-INHIBITING AGENT. IV. EFFECTS OF CHLOROQUINE ON MALIGNANT LYMPHOMAS. , 1964, Acta medicinae Okayama.

[2]  D. Klionsky,et al.  A genomic screen for yeast mutants defective in selective mitochondria autophagy. , 2009, Molecular biology of the cell.

[3]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[4]  S. Kao,et al.  Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. , 2010, Oral diseases.

[5]  Chenguang Wang,et al.  Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution , 2010, Cell cycle.

[6]  Andrew M Campbell,et al.  Mitochondrial membrane cholesterol, the voltage dependent anion channel (VDAC), and the Warburg effect , 2008, Journal of bioenergetics and biomembranes.

[7]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[8]  F. Zaccardi,et al.  Role of asymmetric-dimethyl-L-arginine (ADMA) and nitrite/nitrate (NOx) in the pathogenesis of oxidative stress in female subjects with uncomplicated type 1 diabetes mellitus. , 2009, Diabetes research and clinical practice.

[9]  K. G. Rajesh,et al.  dl-3-Hydroxybutyrate administration prevents myocardial damage after coronary occlusion in rat hearts. , 2002, American journal of physiology. Heart and circulatory physiology.

[10]  K. Abe,et al.  Increased autophagy in transgenic mice with a G93A mutant SOD1 gene , 2007, Brain Research.

[11]  H. Rui,et al.  Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence , 2010, Cancer biology & therapy.

[12]  P. Fortina,et al.  Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the “reverse Warburg effect”: A transcriptional informatics analysis with validation , 2010, Cell cycle.

[13]  Mina J. Bissell,et al.  Quis custodiet ipsos custodies: who watches the watchmen? , 2009, The American journal of pathology.

[14]  N. Weissmann,et al.  Increased protein arginine methylation in chronic hypoxia: role of protein arginine methyltransferases. , 2006, American journal of respiratory cell and molecular biology.

[15]  N. Jamieson,et al.  Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms. , 2009, Biochimica et biophysica acta.

[16]  M. L. Goodstein,et al.  The effect of an acute fast on human head and neck carcinoma xenograft. Growth effects on an 'isolated tumor vascular pedicle' in the nude rat. , 1993, Archives of otolaryngology--head & neck surgery.

[17]  F. Palm,et al.  Cellular ADMA: regulation and action. , 2009, Pharmacological research.

[18]  C. Black,et al.  Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine. , 2006, Rheumatology.

[19]  F. Sotgia,et al.  Towards a new “stromal-based” classification system for human breast cancer prognosis and therapy , 2009, Cell cycle.

[20]  R. Veech.  The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[21]  L. Sauer,et al.  Stimulation of tumor growth in adult rats in vivo during acute streptozotocin-induced diabetes. , 1987, Cancer research.

[22]  A. Namane,et al.  Protein sequencing and identification using tandem mass spectrometry. Edited by Michael Kinter, Nicholas E. Sherman, published by Wiley-Interscience Series on Mass Spectrometry, 2000, 301 p. , 2002 .

[23]  J. Mesirov,et al.  Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. , 2008, Cancer research.

[24]  H. Dvorak.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[25]  M. Bitzer,et al.  Caveolin-1 Regulates Transforming Growth Factor (TGF)-β/SMAD Signaling through an Interaction with the TGF-β Type I Receptor* , 2001, The Journal of Biological Chemistry.

[26]  R. Veech,et al.  Ketoacids? Good medicine? , 2003, Transactions of the American Clinical and Climatological Association.

[27]  S. Black,et al.  Asymmetric dimethylarginine inhibits HSP90 activity in pulmonary arterial endothelial cells: role of mitochondrial dysfunction. , 2008, American journal of physiology. Cell physiology.

[28]  N. Sherman,et al.  Protein Sequencing and Identification Using Tandem Mass Spectrometry: Kinter/Tandem Mass Spectrometry , 2000 .

[29]  M. Bissell,et al.  Breast cancer by proxy: can the microenvironment be both the cause and consequence? , 2009, Trends in molecular medicine.

[30]  L. Belloli,et al.  Systemic Sclerosis and Cancer , 2009, International journal of immunopathology and pharmacology.

[31]  J. LaManna,et al.  Neuroprotection in Diet-Induced Ketotic Rat Brain after Focal Ischemia , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  G. Giannakoulas,et al.  Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension. , 2008, Rheumatology.

[33]  H. Rui,et al.  Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer , 2009, Cancer biology & therapy.

[34]  F. Sotgia,et al.  An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. , 2009, The American journal of pathology.

[35]  N. Camougrand,et al.  Glutathione participates in the regulation of mitophagy in yeast , 2009, Autophagy.

[36]  F. Sotgia,et al.  Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers , 2010, Cancer biology & therapy.

[37]  S. Chiou,et al.  miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. , 2010, Cancer research.

[38]  Toshio Mori.  Studies on the Treatment of Malignant Tumors with Fibroblast-inhibiting Agent , 1970 .

[39]  G. Christ,et al.  Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. , 2001, The Journal of biological chemistry.

[40]  A. Tsirigos,et al.  Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: Similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling" , 2010, Aging.

[41]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Rosenberg,et al.  Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 down-regulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy , 2008, Cancer biology & therapy.

[43]  Britton Chance,et al.  Ketone Bodies, Potential Therapeutic Uses , 2001, IUBMB life.

[44]  Zongguang Zhou,et al.  Clinicopathological Significance of microRNA-31, -143 and -145 Expression in Colorectal Cancer , 2009, Disease markers.

[45]  J. Pouysségur,et al.  Hypoxia-induced autophagy: cell death or cell survival? , 2010, Current opinion in cell biology.

[46]  D. Dinh,et al.  Cathepsin B facilitates autophagy-mediated apoptosis in SPARC overexpressed primitive neuroectodermal tumor cells , 2010, Cell Death and Differentiation.

[47]  Mina J Bissell,et al.  The organizing principle: microenvironmental influences in the normal and malignant breast. , 2002, Differentiation; research in biological diversity.

[48]  C. Restall,et al.  Stromal cell expression of caveolin-1 predicts outcome in breast cancer. , 2009, The American journal of pathology.

[49]  Jonathan Pevsner,et al.  HIF-dependent antitumorigenic effect of antioxidants in vivo. , 2007, Cancer cell.

[50]  F. Pépin,et al.  Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.

[51]  J. Gailit,et al.  The differentiation and function of myofibroblasts is regulated by mast cell mediators. , 2001, The Journal of investigative dermatology.

[52]  A. Tsirigos,et al.  Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: Evidence for stromal-epithelial metabolic coupling , 2010, Cell cycle.

[53]  S. Jimenez,et al.  Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts. , 2009, The American journal of pathology.

[54]  D. Klionsky,et al.  A genomic screen for yeast mutants defective in mitophagy , 2010, Autophagy.

[55]  A. Kimchi,et al.  The paradox of autophagy and its implication in cancer etiology and therapy , 2009, Apoptosis.

[56]  S. Dimauro,et al.  Lactic Acidosis and Mitochondrial Myopathy Associated with Deficiency of Several Components of Complex III of the Respiratory Chain , 1984, Pediatric Research.

[57]  I. Kimura,et al.  STUDIES ON THE TREATMENT OF MALIGNANT TUMORS WITH FIBROBLAST-INHIBITING AGENT. II. EFFECTS OF CHLOROQUINE ON ANIMAL TUMORS. , 1963, Acta medicinae Okayama.

[58]  P. Strålfors,et al.  Attenuated mTOR Signaling and Enhanced Autophagy in Adipocytes from Obese Patients with Type 2 Diabetes , 2010, Molecular medicine.

[59]  M. Milburn,et al.  Analysis of the adult human plasma metabolome. , 2008, Pharmacogenomics.

[60]  M. Gaestel,et al.  p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication , 2010, Proceedings of the National Academy of Sciences.

[61]  Hoyun Lee,et al.  The efficacy and selectivity of tumor cell killing by Akt inhibitors are substantially increased by chloroquine. , 2008, Bioorganic & medicinal chemistry.

[62]  R. Vasan,et al.  Review article: Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus , 2010, Diabetes & vascular disease research.

[63]  A. Nicolucci.  Epidemiological aspects of neoplasms in diabetes , 2010, Acta Diabetologica.

[64]  J. Loscalzo,et al.  MicroRNA-210: A unique and pleiotropic hypoxamir , 2010, Cell cycle.

[65]  Quynh-Thu Le,et al.  Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer. , 2010, Translational oncology.

[66]  Lin He,et al.  The guardian's little helper: microRNAs in the p53 tumor suppressor network. , 2007, Cancer research.

[67]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[68]  J. Loeffler,et al.  Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Alok Kumar,et al.  Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[70]  T. Ishigami,et al.  Overexpression and altered subcellular localization of autophagy-related 16-like 1 in human oral squamous-cell carcinoma: correlation with lymphovascular invasion and lymph-node metastasis. , 2009, Human pathology.

[71]  F. Sotgia,et al.  Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: Implications for breast cancer and DCIS therapy with autophagy inhibitors , 2010, Cell cycle.

[72]  I. Kimura,et al.  STUDIES ON THE TREATMENT OF MALIGNANT TUMORS WITH FIBROBLAST-INHIBITING AGENT. I. FIBROBLAST-INHIBITING ACTION OF CHLOROQUINE. , 1963, Acta medicinae Okayama.

[73]  B. Robinson,et al.  Defective intramitochondrial NADH oxidation in skin fibroblasts from an infant with fatal neonatal lacticacidemia. , 1985, American journal of human genetics.

[74]  F. Fornai,et al.  Autophagy and amyotrophic lateral sclerosis: The multiple roles of lithium , 2008, Autophagy.

[75]  I. Kimura,et al.  STUDIES ON THE TREATMENT OF MALIGNANT TUMORS WITH FIBROBLAST-INHIBITING AGENT. 3. EFFECTS OF CHLOROQUINE ON HUMAN CANCERS. , 1964, Acta medicinae Okayama.

[76]  J. Garlick,et al.  Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. , 1997, Journal of immunology.

[77]  P. Fortina,et al.  The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma , 2009, Cell cycle.

[78]  Ji Min Kim,et al.  The anti-apoptotic action of 5-hydroxyindole: protection of mitochondrial integrity. , 2010, Biological & pharmaceutical bulletin.

[79]  J. Pouysségur,et al.  Hypoxia-Induced Autophagy Is Mediated through Hypoxia-Inducible Factor Induction of BNIP3 and BNIP3L via Their BH3 Domains , 2009, Molecular and Cellular Biology.

[80]  A. Szuba,et al.  Asymmetric dimethylarginine in hematological malignancies: a preliminary study , 2008, Leukemia & lymphoma.

[81]  F. Sotgia,et al.  An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease spread and epithelial Akt activation , 2009, Cell cycle.